Display options
Share it on

Gut Pathog. 2012 Aug 03;4(1):8. doi: 10.1186/1757-4749-4-8.

Quorum sensing in the probiotic bacterium Escherichia coli Nissle 1917 (Mutaflor) - evidence that furanosyl borate diester (AI-2) is influencing the cytokine expression in the DSS colitis mouse model.

Gut pathogens

Christoph A Jacobi, Stefanie Grundler, Chih-Jen Hsieh, Julia Stefanie Frick, Patrick Adam, Georg Lamprecht, Ingo B Autenrieth, Michael Gregor, Peter Malfertheiner

Affiliations

  1. Department of Internal Medicine I, University clinic Tübingen, Otfried Müllerstr, 10, 72076, Tübingen, Germany. [email protected].

PMID: 22862922 PMCID: PMC3480846 DOI: 10.1186/1757-4749-4-8

Abstract

BACKGROUND: "Quorum sensing" (QS) is the phenomenon which allows single bacterial cells to measure the concentration of bacterial signal molecules. Two principle different QS systems are known, the Autoinducer 1 system (AI-1) for the intraspecies communication using different Acyl-homoserine lactones (AHL) and AI-2 for the interspecies communication. Aim of this study was to investigate QS of Escherichia coli Nissle 1917 (Mutaflor).

RESULTS: While E. coli Nissle is producing AI-2 in a density dependent manner, no AI-1 was produced. To study the effect of AI-2 in the DSS (dextran sulphate sodium) induced mouse model of acute colitis, we silenced the corresponding gene luxS by intron insertion. The mutant bacterium E. coli Nissle::luxS was equally effective in colonizing the colon and the mutation turned out to be 100% stable during the course of the experiment. Isolating RNA from the colon mucosa and performing semiquantitative RT PCR, we were able to show that the expression of the pro-inflammatory cytokine IFN-y was suppressed in mice being infected with the E. coli Nissle wild type. Mice infected with the E. coli Nissle::luxS mutant showed a suppressed expression of IL-10 compared to uninfected mice, while the expression of the pro-inflammatory cytokines IL-6 and TNF-α was higher in these mice. The expression of mBD-1 was suppressed in mice being infected with the mutant in comparison to the mice not infected or infected with the wild type. No differences were seen in the histological examination of the colon sections in the different groups of mice.

CONCLUSIONS: E. coli Nissle is producing AI-2 molecules, which are influencing the expression of cytokines in the mucosa of the colon in the DSS mice. However, if QS has a direct influence on the probiotic properties of E. coli Nissle remains to be elucidated.

References

  1. J Bacteriol. 2006 Feb;188(4):1451-61 - PubMed
  2. Jpn J Infect Dis. 2008 Sep;61(5):402-6 - PubMed
  3. J Bacteriol. 2007 Feb;189(3):860-71 - PubMed
  4. J Bacteriol. 1970 Oct;104(1):313-22 - PubMed
  5. Gut. 2004 Nov;53(11):1617-23 - PubMed
  6. Aliment Pharmacol Ther. 1997 Oct;11(5):853-8 - PubMed
  7. J Bacteriol. 2008 Feb;190(3):1045-53 - PubMed
  8. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7046-50 - PubMed
  9. J Bacteriol. 2001 Sep;183(17):5187-97 - PubMed
  10. Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21128-33 - PubMed
  11. Lab Invest. 1993 Aug;69(2):238-49 - PubMed
  12. J Biol Chem. 2009 Jul 17;284(29):19744-53 - PubMed
  13. Philos Trans R Soc Lond B Biol Sci. 2000 May 29;355(1397):667-80 - PubMed
  14. Syst Appl Microbiol. 1999 Dec;22(4):493-506 - PubMed
  15. Nature. 2003 Apr 3;422(6931):522-6 - PubMed
  16. Dig Dis. 2011;29(6):600-7 - PubMed
  17. J Bacteriol. 1994 Jan;176(2):269-75 - PubMed
  18. Infect Immun. 2004 Oct;72(10):5750-8 - PubMed
  19. Infect Immun. 2003 Mar;71(3):1109-15 - PubMed
  20. Gut. 2002 Nov;51(5):659-64 - PubMed
  21. J Med Microbiol. 2010 Apr;59(Pt 4):392-399 - PubMed
  22. Annu Rev Microbiol. 2001;55:165-99 - PubMed
  23. Mol Microbiol. 2001 Jul;41(2):463-76 - PubMed
  24. Infect Immun. 2004 May;72(5):2772-9 - PubMed
  25. Oncogene. 2004 Jun 17;23(28):4894-902 - PubMed
  26. Science. 1988 Jan 29;239(4839):487-91 - PubMed
  27. Infect Immun. 2009 Jul;77(7):2995-3003 - PubMed
  28. Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9427-31 - PubMed
  29. Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1639-44 - PubMed
  30. Infect Immun. 2003 Oct;71(10):5785-93 - PubMed
  31. Lancet. 1999 Aug 21;354(9179):635-9 - PubMed
  32. Appl Environ Microbiol. 2007 Jul;73(13):4259-67 - PubMed
  33. Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3129-34 - PubMed
  34. FEMS Immunol Med Microbiol. 2004 Oct 1;42(2):173-80 - PubMed
  35. Inflamm Bowel Dis. 2003 Jul;9(4):215-23 - PubMed
  36. BMC Microbiol. 2010 Nov 16;10:293 - PubMed
  37. Mol Microbiol. 1999 Sep;33(6):1267-77 - PubMed
  38. Appl Environ Microbiol. 2009 Feb;75(4):1165-72 - PubMed
  39. Curr Opin Pulm Med. 2008 May;14(3):168-75 - PubMed
  40. Int J Food Microbiol. 2009 Nov 15;135(3):295-302 - PubMed
  41. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3526-31 - PubMed
  42. Infect Immun. 2006 Jul;74(7):4075-82 - PubMed
  43. Med Welt. 1961 Jul 29;29-30:1519-23 - PubMed
  44. Clin Microbiol Infect. 2005 Jun;11(6):472-9 - PubMed
  45. FEMS Microbiol Lett. 2000 Mar 15;184(2):273-8 - PubMed
  46. Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6036-41 - PubMed
  47. FEMS Immunol Med Microbiol. 2004 Jun 1;41(2):169-76 - PubMed

Publication Types